Covered, barely — and flat for four years. A quarterly payer at $0.59 a share, declared September 17, 2026 and paid October 30, 2026, unchanged from the prior quarter and the prior year — and unchanged since July 2022. Coverage is thin: second-quarter FFO of $0.69 a share covers the $0.59 dividend at an 85.5% payout, down from $0.73 of FFO a year earlier, with $0.07 of that fall from the initial operations of the new Hampden House development. Excluding Hampden House, FFO rose $1.8 million on higher residential and commercial base rent, and same-property residential leasing was 97.3% at June 30, 2026 against 90.5% a year earlier. The 8.04% yield is therefore compensation for a thin cushion, a four-year flat dividend, and a 10-year price return of about −53% — but no return-of-capital evidence was verified, so this is a warning, not a trap verdict: the dividend is still paid out of FFO, not out of capital returned. For a REIT, the House reads FFO payout — never the EPS payout, which depreciation makes meaningless. Saul Centers reports FFO, not AFFO; the payout basis is stated here.
Key risk: Hampden House lease-up and a thin cushion in a concentrated portfolio — at August 3, 2026 only 64.2% of Hampden House's 366 residential units were leased and occupied, and over 85% of property operating income comes from the Washington, DC/Baltimore area. With FFO covering the dividend at 85.5%, there is little room for a leasing miss or a rate shock before the $0.59 rate is questioned.
Changes if: FFO falls to or below the $0.59 quarterly dividend (a payout at or above 100%), Hampden House lease-up stalls, or the dividend stays flat for a fifth year while FFO keeps falling. The cushion, not the headline yield, is the tripwire.
- !FFO coverage check: 85.5% of second-quarter FFO paid out — $0.59 against $0.69, down from $0.73 a year earlier. Covered, but the margin is $0.10 a share, and $0.07 of the year-over-year FFO fall was Hampden House's initial operations.
- !Yield check: 8.04% indicated — $0.59/qtr × 4 at the $29.35 close on Oct. 23, 2026. High because the price has fallen and the dividend has not grown: flat since July 2022, with a 10-year price return of about −53%. That is distress-yield evidence, not trap proof — no return-of-capital funding was verified — so the grade stays warn.
- !Dividend growth check: No raise since July 2022: $0.59 every quarter for over four years while FFO fell year over year in the second quarter. A payer that cannot raise is not yet a cutter, but it is not compounding either.
What this grade doesn't say: It screens the dividend only — covered, real, compounding. It says nothing about valuation or price: a well-covered payer can still be overpriced, and its price can still fall.